Biocon Ltd.
| BSE: 532523 |
Sector: Health care |
| NSE: BIOCON |
ISIN Code: INE376G01013 |
|
BSE
00:00 | 24 Apr 2020
|
Biocon Ltd
|
|
NSE
05:30 | 01 Jan 1970
|
Biocon Ltd
|
Notice: Undefined property: stdClass::$market_capital_for_nse in
/usr2/unibs/application/modules/live-market/views/scripts/company/bs-new-bse-nse-block.php on line
17
| OPEN |
342.05 |
| PREVIOUS CLOSE |
347.55 |
| VOLUME |
341566 |
| 52-Week high |
367.80 |
| 52-Week low |
211.30 |
| P/E |
141.21 |
| Mkt Cap.(Rs cr) |
42,870 |
| Buy Price |
356.30 |
| Buy Qty |
100.00 |
| Sell Price |
357.25 |
| Sell Qty |
51.00 |
| OPEN |
|
| PREVIOUS CLOSE |
|
| VOLUME |
|
| 52-Week high |
367.80 |
| 52-Week low |
211.05 |
| P/E |
141.21 |
| Mkt Cap.(Rs cr) |
0 |
| Buy Price |
|
| Buy Qty |
|
| Sell Price |
|
| Sell Qty |
|
| OPEN |
342.05 |
| CLOSE |
347.55 |
| VOLUME |
341566 |
| 52-Week high |
367.80 |
| 52-Week low |
211.30 |
| P/E |
141.21 |
| Mkt Cap.(Rs cr) |
42,870 |
| Buy Price |
356.30 |
| Buy Qty |
100.00 |
| Sell Price |
357.25 |
| Sell Qty |
51.00 |
| OPEN |
|
| PREVIOUS CLOSE |
|
| VOLUME |
|
| 52-Week high |
367.80 |
| 52-Week low |
211.05 |
| P/E |
141.21 |
| Mkt Cap.(Rs cr) |
42,870 |
| Buy Price |
|
| Buy Qty |
|
| Sell Price |
|
| Sell Qty |
|
Biocon Ltd. (BIOCON) - Company Information
Biocon Ltd
Biocon Limited is India's largest and fully-integrated innovation-led biopharmaceutical company. Some of its key brands are INSUGEN (rh-insulin) BASALOG (Glargine) CANMAb (Trastuzumab) BIOMAb-EGFR (Nimotuzumab) KRABEVAA (Bevacizumab) and ALZUMAb (Itolizumab) a 'first in class' anti-CD6 monoclonal antibody. The company has a rich pipeline of Biosimilars and Novel Biologics at various stages of deve...> More
| COMPANY INFORMATION |
| Executive Chairperson : |
Kiran Mazumdar Shaw |
| Vice Chairman : |
John Shaw |
| Director : |
Ravi Mazumdar |
| Independent Director : |
Russell Walls |
| Independent Director : |
Mary Harney |
| Independent Director : |
Daniel M Bradbury |
| Independent Director : |
Jeremy Levin |
| Independent Director : |
Vijay Kumar Kuchroo |
| Independent Director : |
M Damodaran |
| Independent Director : |
Bobby Kanubhai Parikh |
| Company Secretary : |
Mayank Verma |
| Managing Director & CEO : |
SIDDHARTH MITTAL |
| AUDITOR : |
B S R & Co LLP |
| IND NAME : |
Pharmaceuticals - Indian - Bulk Drugs & Formln |
| HOUSE NAME : |
Indian Private |
| Registered office |
| 20th KM Hosur Road Hebbagodi, Electronic City P O,Bangalore,Karnataka-560100 |
| Ph : 91-80-28082808 |
| WEBSITE : http://www.biocon.com |
| E-mail : co.secretary@biocon.com |
Notice: Undefined variable: mediaAbsUrl in
/usr2/unibs/application/modules/live-market/controllers/CompanyController.php on line
4511
